TARGETING DUAL PATHWAYS IN REFRACTORY COCCYDYNIA

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

June 2, 2024

Conditions
Coccydynia
Interventions
PROCEDURE

Ganglion Impar Block

The ganglion impar was accessed with a Quincke spinal needle, transsacrococcygeally (from between the first and second coccygeal vertebrae if sacrococcygeal access could not be achieved). Then, 1 mL of non-ionic contrast medium was administered, and fluoroscopic anterior-posterior and lateral imaging was performed to confirm the appropriate spread of contrast (Figure 1). After this confirmation, 2 mL of 0.5% bupivacaine, 2 mL of saline, and 40 mg of methylprednisolone acetate were injected.

PROCEDURE

Ganglion Impar Block and Pericoccygeal Injection

In the combination therapy group who underwent pericoccygeal injection in addition to impar block, following the same procedure, 5 mL of 0.25% bupivacaine and 20 mg of methylprednisolone were injected into the posterior pericoccygeal region while the needle was withdrawn, thus also targeting blockade of the anococcygeal nerve.

Trial Locations (1)

34303

Health Sciences University Istanbul Kanuni Sultan Süleyman Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER